IQI
IRWD icon

Integrated Quantitative Investments’s Ironwood Pharmaceuticals IRWD Stock Holding History

Integrated Quantitative Investments’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$394K Sell
93,689
-458,415
-83% -$1.77M 0.06% 293
2026
Q1 		$1.94M Buy
552,104
+449,450
+438% +$1.84M 0.35% 77
2025
Q4 		$346K Buy
+102,654
New +$267K 0.07% 308

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Integrated Quantitative Investments's IRWD Position: Q2 2026 in Review

Integrated Quantitative Investments reduced its Ironwood Pharmaceuticals (IRWD) stake by 83% in Q2 2026, selling an estimated $1.77M and leaving 93,689 shares worth $394K. The position accounts for 0.06% of the portfolio, ranked #293.

Integrated Quantitative Investments first reported a position in IRWD in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.94M in Q1 2026. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Integrated Quantitative Investments held 93,689 shares of Ironwood Pharmaceuticals worth $394K as of Q2 2026.
  • Integrated Quantitative Investments sold 458,415 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $1.77M.
  • Ironwood Pharmaceuticals made up 0.06% of Integrated Quantitative Investments's portfolio in Q2 2026, its #293 holding.
  • Integrated Quantitative Investments first reported a position in Ironwood Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Integrated Quantitative Investments's Ironwood Pharmaceuticals position peaked at $1.94M in Q1 2026.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Integrated Quantitative Investments's 13F filing for Q2 2026, filed 14 Aug 2026.